Abstract
In HIV patients, HCV co-infection has been associated with an increased risk of progressive multifocal leukoencephalopathy (PML). Furthermore, PML has also been described in patients with cirrhosis, whether related to HCV infection or not. We describe here the case of a HIV/HCV co-infected patient with cirrhosis who developed PML despite HIV suppression and CD4 cell count above 250/mm3 for 2 years. Immunological studies performed at onset of PML and before HCV therapy showed a decrease in naïve CD4 cells (CD45RA+CCR7+CD27+ CD4+ T cells − 23% cells, i.e. 75/mm3) and NK lymphopenia with abnormal and activated NK cells (CD3− CD16+ and/or CD56+) (5% lymphocytes, i.e. 58/mm3, CD69 91%, NKp30 26%). This impaired immunity, possibly related to HIV infection, or HCV infection or cirrhosis, or a combination thereof, could have led to the development of PML.
Similar content being viewed by others
References
Acott PD (2013) Natural killer cell response to BK virus infection in polyoma virus–associated nephropathy of renal transplant recipients. Kidney Int 84:233–235
Aung AK, Robinson J, Hey P, Lehmann M, Chow Y, Stark RJ, Bosco JJ (2019) Progressive multifocal leukoencephalopathy secondary to hepatitis C virus infection-related T-cell lymphopenia: brief communications. Intern Med J 49:114–118
Crossley KM, Agnihotri S, Chaganti J, Rodriguez ML, McNally LP, Venna N et al (2016) Recurrence of progressive multifocal leukoencephalopathy despite immune recovery in two HIV seropositive individuals. J Neuro-Oncol 22:541–545
Dubois E, Ruschil C, Bischof F (2015) Low frequencies of central memory CD4 T cells in progressive multifocal leukoencephalopathy. Neurology - Neuroimmunology Neuroinflammation 2:e177
Gan Y, Liu R, Wu W, Bomprezzi R, Shi F-D (2012) Antibody to α4 integrin suppresses natural killer cells infiltration in central nervous system in experimental autoimmune encephalomyelitis. J Neuroimmunol 247:9–15
Gheuens S, Pierone G, Peeters P, Koralnik IJ (2010) Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression. J Neurol Neurosurg Psychiatry 81:247–254
Guihot A, Bourgarit A, Carcelain G, Autran B (2011) Immune reconstitution after a decade of combined antiretroviral therapies for human immunodeficiency virus. Trends Immunol 32:131–137
Jiang H, Wang X, Luo B, Cong X, Jin Q, Qin H, Zhang HY, Kong XS, Wei L, Feng B (2019) Direct antiviral agents upregulate natural killer cell potential activity in chronic hepatitis C patients. Clin Exp Med 19:299–308
Kaczmarek DJ, Kokordelis P, Krämer B, Glässner A, Wolter F, Goeser F, Lutz P, Schwarze-Zander C, Boesecke C, Strassburg CP, Rockstroh JK, Spengler U, Nattermann J (2017) Alterations of the NK cell pool in HIV/HCV co-infection. PLoS One 12:e0174465
Li T, Tubiana R, Katlama C, Calvez V, Mohand HA, Autran B (1998) Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease. Lancet 351:1682–1686
Lima MA, Auriel E, Wuthrich C, Borenstein NM, Koralnik IJ (2005) Progressive multifocal leukoencephalopathy as a complication of hepatitis C virus treatment in an HIV-negative patient. Clin Infect Dis 41:417–419
Márquez M, Fernández-Gutiérrez C, Montes-de-Oca M, Blanco MJ, Brun F, Rodríguez-Ramos C, Girón-González JA (2009) Chronic antigenic stimuli as a possible explanation for the immunodepression caused by liver cirrhosis. Clin Exp Immunol 158:219–229
Melliez H, Mary-Krause M, Bocket L, Guiguet M, Abgrall S, De Truchis P et al (2018) Risk of progressive multifocal leukoencephalopathy in the combination antiretroviral therapy era in the French Hospital Database on Human Immunodeficiency Virus (ANRS-C4). Clin Infect Dis 67:275–282
Sandberg JK, Falconer K, Gonzalez VD (2010) Chronic immune activation in the T cell compartment of HCV/HIV-1 co-infected patients. Virulence 1:177–179
Scully E, Alter G (2016) NK cells in HIV disease. Current HIV/AIDS Reports 13:85–94
Strunz B, Hengst J, Deterding K, Manns MP, Cornberg M, Ljunggren H-G, Wedemeyer H, Björkström NK (2018) Chronic hepatitis C virus infection irreversibly impacts human natural killer cell repertoire diversity. Nat Commun 9:2275. https://doi.org/10.1038/s41467-018-04685-9
Stuehler C, Bernardini C, Elzi L, Stoeckle M, Zimmerli S, Furrer H, et al. Immune recovery in HIV-infected patients after Candida esophagitis is impaired despite long-term antiretroviral therapy: AIDS 2016; 30:1923–1933
Telatin V, Nicoli F, Frasson C, Menegotto N, Barbaro F, Castelli E et al (2019) In chronic hepatitis C infection, myeloid-derived suppressor cell accumulation and T cell dysfunctions revert partially and late after successful direct-acting antiviral treatment. Front Cell Infect Microbiol 9:190
Yoon JC (2016) Natural killer cells in hepatitis C: current progress. World J Gastroenterol 22:1449–1460
Acknowledgements
We thank Fiona Ecarnot, PhD (EA3920, University Hospital Besancon, France), for editorial assistance.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
Yes
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Hentzien, M., Guihot, A., de Maindreville, D. et al. Progressive multifocal leukoencephalopathy despite immune recovery in a HIV/HCV co-infected patient. J. Neurovirol. 26, 607–610 (2020). https://doi.org/10.1007/s13365-020-00848-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13365-020-00848-x